(R)-carnitine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Meta-analysis suggested a significant reduction in plasma concentrations of total cholesterol (WMD: −9.49 mg/dL, 95% CI: −17.07, −1.92, p = 0.014) and a borderline significant trend in reduction of LDL-C (WMD: −4.67 mg/dL, 95% CI: −9.78, 0.45, p = 0.074) following L-carnitine supplementation.”
Quoted verbatim from Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- 1 g 3 times per week to 4 g/day across included trials; 1 to 24 weeks
- Population
- Adults in 7 treatment arms of randomised trials (intravenous and oral L-carnitine pooled) reporting total cholesterol, versus control
Effect -9.49 mean difference, 95% CI -17.07 to -1.92
Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials.2016PMID:26754058Industry fundedPermalink
Keep reading
- Everything the graph holds on (R)-carnitine
- Every compound studied against Total cholesterol (TC)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45QKQBSGAJPBZBBZ1HRKY5C